XCUR

Exicure INC

-$116.0K

Net Activity

Institutions Holding

18

Popularity Rank

#8457

Avg Weight

0.00%

Total Value

$687.0K

Ownership Trend

18 institutions currently hold XCUR, with 7 net buyers and 4 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Majority Increased

Based on recent trading activity

Net Selling Institutions

4

Net Buying Institutions

7

Key Holders

View all 18 holding institutions

Quarterly Activity

Recent Activity

+$200.1K

Total Buy Value

$27.4K

Total Sell Value

New buy4
Trim2
Add3
Sold out2

7

Net Buyers

4

Net Sellers

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

No Form 144 planned sale filings in the last 90 days

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

1

Filings (14d)

Data as of 2026-06-30
2026-06-30

Exicure, a biotechnology company, announced board changes effective June 30, 2026. Director Ham Jung Kyu resigned, and the board expanded from five to six members. Two new directors—Go Jin Young and Han Eui Seok—were appointed as Class III directors. The company also formed a Compensation Committee, with Han as Chair and Dongho Lee as a member.

View Full Filing (SEC EDGAR)

View all Form 8-K filings

FAQ

Who are the top institutional investors holding EXICURE INC (XCUR)?
Major stakeholders currently include Carlyle Group Inc. ($239.6K), Geode Capital Management, LLC ($157.6K), Vanguard Capital Management LLC ($140.8K). Based on the latest 13F filings, there are a total of 18 tracked investment funds and institutions maintaining positions in XCUR.
What is the overall institutional sentiment toward XCUR recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $116.0K, driven by 7 managers accumulating shares while 4 reduced their exposure.
Which institutions have been selling or reducing their XCUR positions?
In the latest period, 2 funds trimmed their holdings, and 2 managers completely exited their positions. The aggregate reported sell value was $27.4K.
Are there any notable investors adding XCUR to their portfolios?
Yes, buying activity remains notable. 4 institutions opened new positions in {ticker}, and 3 existing holders added to their shares. The total reported buy value for the quarter amounted to $200.1K.

Related Stocks